SI1347987T1 - Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents - Google Patents

Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents

Info

Publication number
SI1347987T1
SI1347987T1 SI200130228T SI200130228T SI1347987T1 SI 1347987 T1 SI1347987 T1 SI 1347987T1 SI 200130228 T SI200130228 T SI 200130228T SI 200130228 T SI200130228 T SI 200130228T SI 1347987 T1 SI1347987 T1 SI 1347987T1
Authority
SI
Slovenia
Prior art keywords
sugar
substituted
hypocholesterolemic agents
azetidinones useful
azetidinones
Prior art date
Application number
SI200130228T
Other languages
English (en)
Slovenian (sl)
Inventor
Anima Ghosal
Shmuel Zbaida
Swapan K. Chowdhury
Robert M. Iannucci
Wenqing Feng
Kevin B. Alton
James E. Patrick
Harry R. Davis
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22973953&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1347987(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of SI1347987T1 publication Critical patent/SI1347987T1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200130228T 2000-12-20 2001-12-17 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents SI1347987T1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25687500P 2000-12-20 2000-12-20
PCT/US2001/049127 WO2002050090A1 (fr) 2000-12-20 2001-12-17 2-azetidinones substitues par le sucre utilises comme hypocholesterolemiants

Publications (1)

Publication Number Publication Date
SI1347987T1 true SI1347987T1 (en) 2005-02-28

Family

ID=22973953

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200130228T SI1347987T1 (en) 2000-12-20 2001-12-17 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
SI200130760T SI1593670T1 (sl) 2000-12-20 2001-12-17 S hidroksi substituirani 2-azetidinoni, uporabni kot sredstva za zniĹľevanje holesterola

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200130760T SI1593670T1 (sl) 2000-12-20 2001-12-17 S hidroksi substituirani 2-azetidinoni, uporabni kot sredstva za zniĹľevanje holesterola

Country Status (35)

Country Link
US (1) US20020137690A1 (fr)
EP (1) EP1347987B1 (fr)
JP (2) JP4351842B2 (fr)
KR (1) KR100883461B1 (fr)
CN (1) CN100475829C (fr)
AR (1) AR035611A1 (fr)
AT (2) ATE369334T1 (fr)
AU (2) AU3104902A (fr)
BR (1) BR0116212A (fr)
CA (1) CA2432798C (fr)
CY (1) CY1106912T1 (fr)
CZ (1) CZ302193B6 (fr)
DE (2) DE60129863T2 (fr)
DK (2) DK1593670T3 (fr)
EC (1) ECSP034659A (fr)
ES (2) ES2287826T3 (fr)
GE (1) GEP20053548B (fr)
HK (2) HK1056735A1 (fr)
HU (1) HUP0302269A3 (fr)
IL (1) IL155771A0 (fr)
MA (1) MA26975A1 (fr)
MX (1) MXPA03005671A (fr)
MY (1) MY129148A (fr)
NO (2) NO326981B1 (fr)
NZ (1) NZ525722A (fr)
PE (1) PE20020718A1 (fr)
PL (1) PL208242B1 (fr)
PT (2) PT1347987E (fr)
RU (1) RU2297422C2 (fr)
SI (2) SI1347987T1 (fr)
SK (1) SK286703B6 (fr)
TR (1) TR200402758T4 (fr)
TW (1) TWI316942B (fr)
WO (1) WO2002050090A1 (fr)
ZA (1) ZA200303694B (fr)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60206365T2 (de) 2001-03-28 2006-07-06 Schering Corporation, Kenilworth Verfahren für die enantioselektive synthese von azetidinon-zwischenprodukten
GB0215579D0 (en) * 2002-07-05 2002-08-14 Astrazeneca Ab Chemical compounds
AR040588A1 (es) 2002-07-26 2005-04-13 Schering Corp Formulacion farmaceutica que comprende un inhibidor de la absorcion del colesterol y un inhibidor de una hmg- co a reductasa
JP2005015434A (ja) * 2003-06-27 2005-01-20 Kotobuki Seiyaku Kk 血清コレステロール低下剤或はアテローム性硬化症の予防又は治療剤
EP1522541A1 (fr) * 2003-10-07 2005-04-13 Lipideon Biotechnology AG Nouveaux composés hypocholesterolémiques
EP1918000A2 (fr) 2003-11-05 2008-05-07 Schering Corporation Combinaisons d'agents de modulation lipide et azétidinones substitués et traitements pour conditions vasculaires
US7871998B2 (en) * 2003-12-23 2011-01-18 Astrazeneca Ab Diphenylazetidinone derivatives possessing cholesterol absorption inhibitory activity
WO2005062824A2 (fr) 2003-12-23 2005-07-14 Merck & Co., Inc. Composes anti-hypercholesterolemie
GB0329778D0 (en) * 2003-12-23 2004-01-28 Astrazeneca Ab Chemical compounds
EP1807070A1 (fr) * 2004-09-29 2007-07-18 Schering Corporation Combinaisons d'azetidinones substituees et d'antagonistes cb1
US7737155B2 (en) 2005-05-17 2010-06-15 Schering Corporation Nitrogen-containing heterocyclic compounds and methods of use thereof
AR054482A1 (es) * 2005-06-22 2007-06-27 Astrazeneca Ab Derivados de azetidinona para el tratamiento de hiperlipidemias
SA06270191B1 (ar) * 2005-06-22 2010-03-29 استرازينيكا ايه بي مشتقات من 2- أزيتيدينون جديدة باعتبارها مثبطات لامتصاص الكوليسترول لعلاج حالات فرط نسبة الدهون في الدم
EP1849459A1 (fr) * 2006-03-06 2007-10-31 Teva Pharmaceutical Industries Ltd. Compositions d'ézétimibe
TW200811098A (en) 2006-04-27 2008-03-01 Astrazeneca Ab Chemical compounds
RU2492175C2 (ru) * 2007-04-02 2013-09-10 Теракос, Инк. Бензиловые производные гликозидов и способы их применения
US20110243940A1 (en) 2008-12-16 2011-10-06 Schering Corporation Bicyclic pyranone derivatives and methods of use thereof
US20110245209A1 (en) 2008-12-16 2011-10-06 Schering Corporation Pyridopyrimidine derivatives and methods of use thereof
EP2396339B1 (fr) * 2009-02-11 2014-07-02 Dow AgroSciences LLC Compositions pesticides
WO2010100255A1 (fr) 2009-03-06 2010-09-10 Lipideon Biotechnology Ag Compositions pharmaceutiques hypocholestérolémiques
WO2010113175A2 (fr) 2009-04-01 2010-10-07 Matrix Laboratories Ltd Procédé enzymatique pour la préparation de la (s)-5-(4-fluorophényl)-5-hydroxy-1-morpholin-4-yl-pentan-1-one, un intermédiaire de l'ézétimibe et la conversion ultérieure en ézétimibe
CN101993403B (zh) 2009-08-11 2012-07-11 浙江海正药业股份有限公司 氮杂环丁酮类化合物及医药应用
KR101102749B1 (ko) * 2009-11-30 2012-01-05 최길용 곱셈 학습기
KR20150079373A (ko) 2013-12-30 2015-07-08 한미약품 주식회사 에제티미브 및 로수바스타틴을 포함하는 경구용 복합제제
CN105055404B (zh) * 2015-08-19 2017-07-18 四川大学 Hmgcs2抑制剂在制备治疗可卡因成瘾的药物中的用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3595B (en) * 1993-01-21 1995-12-27 Schering Corp Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents
US5631365A (en) * 1993-09-21 1997-05-20 Schering Corporation Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents
US5627176A (en) * 1994-03-25 1997-05-06 Schering Corporation Substituted azetidinone compounds useful as hypocholesterolemic agents
US5633246A (en) * 1994-11-18 1997-05-27 Schering Corporation Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents
ATE219495T1 (de) * 1995-10-31 2002-07-15 Schering Corp Zuckersubstituierte 2-azetidinone, verwendbar als hypocholesterdenische arzneimittel
US5756470A (en) * 1996-10-29 1998-05-26 Schering Corporation Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
AUPQ342599A0 (en) * 1999-10-14 1999-11-04 University Of Melbourne, The Conjugates and uses thereof

Also Published As

Publication number Publication date
ES2230385T3 (es) 2005-05-01
ATE369334T1 (de) 2007-08-15
SK286703B6 (sk) 2009-03-05
AR035611A1 (es) 2004-06-16
DE60106489D1 (de) 2004-11-18
WO2002050090A1 (fr) 2002-06-27
ES2287826T3 (es) 2007-12-16
CZ20031674A3 (cs) 2003-10-15
PE20020718A1 (es) 2002-08-09
DK1593670T3 (da) 2007-11-05
NZ525722A (en) 2004-11-26
NO326981B1 (no) 2009-03-30
ECSP034659A (es) 2003-07-25
BR0116212A (pt) 2003-12-30
AU3104902A (en) 2002-07-01
NO20083737L (no) 2003-08-19
RU2003122520A (ru) 2005-02-27
KR20030063414A (ko) 2003-07-28
EP1347987B1 (fr) 2004-10-13
JP4351842B2 (ja) 2009-10-28
SI1593670T1 (sl) 2007-12-31
DE60129863T2 (de) 2008-04-30
MY129148A (en) 2007-03-30
DE60106489T2 (de) 2005-10-13
HK1084945A1 (en) 2006-08-11
AU2002231049B2 (en) 2006-07-20
PL363237A1 (en) 2004-11-15
DK1347987T3 (da) 2005-01-31
CZ302193B6 (cs) 2010-12-08
RU2297422C2 (ru) 2007-04-20
JP2004516299A (ja) 2004-06-03
CN100475829C (zh) 2009-04-08
CN1483039A (zh) 2004-03-17
CA2432798C (fr) 2007-02-27
IL155771A0 (en) 2003-12-23
KR100883461B1 (ko) 2009-02-16
HUP0302269A2 (hu) 2003-10-28
HK1056735A1 (en) 2004-02-27
WO2002050090A8 (fr) 2004-04-15
GEP20053548B (en) 2005-06-27
PT1347987E (pt) 2005-01-31
CA2432798A1 (fr) 2002-06-27
DE60129863D1 (de) 2007-09-20
PL208242B1 (pl) 2011-04-29
MXPA03005671A (es) 2003-10-06
ZA200303694B (en) 2004-08-13
TR200402758T4 (tr) 2004-11-22
JP2009132745A (ja) 2009-06-18
CY1106912T1 (el) 2012-09-26
ATE279425T1 (de) 2004-10-15
US20020137690A1 (en) 2002-09-26
MA26975A1 (fr) 2004-12-20
PT1593670E (pt) 2007-11-08
TWI316942B (en) 2009-11-11
SK7702003A3 (en) 2003-10-07
NO20032806L (no) 2003-08-19
EP1347987A1 (fr) 2003-10-01
NO20032806D0 (no) 2003-06-19
HUP0302269A3 (en) 2009-08-28

Similar Documents

Publication Publication Date Title
AU3104902A (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
AU2002231049A1 (en) Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents
TW577496U (en) Auger-like drywall screw
GB0120916D0 (en) Working vehicle
AU4089901A (en) Panel
GB2389377B (en) Panel
GB0126009D0 (en) Panel
EP1308369A4 (fr) Vehicule de travail
GB0012205D0 (en) Door
GB2367850B (en) Doors
EP1433906A4 (fr) Panneau
AU2002218529A1 (en) Antilipemic agents
TW534200U (en) Quake-resistant doors
EG23062A (en) Rotary hammer extrusion
AU2772P (en) T90-1-0-1 Telopea speciosissima x Telopea oreades
GB2362414B (en) Door
GB0005973D0 (en) Construction unit
TW427421U (en) Improved quick door
TW418978U (en) Improved quick door
AU144133S (en) Door
PL340515A1 (en) Door
PL110495U1 (en) Door
GB0016137D0 (en) Door dampenner
GB0002148D0 (en) Acoustic panel
GB0005818D0 (en) Hammer